O Shaughnessy Asset Management LLC lifted its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 692.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,971 shares of the company’s stock after acquiring an additional 55,027 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in HCA Healthcare were worth $8,753,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also made changes to their positions in the company. State of Alaska Department of Revenue raised its holdings in HCA Healthcare by 27.7% in the second quarter. State of Alaska Department of Revenue now owns 45,700 shares of the company’s stock worth $4,687,000 after purchasing an additional 9,910 shares in the last quarter. Confluence Investment Management LLC bought a new position in HCA Healthcare in the second quarter worth $283,000. NN Investment Partners Holdings N.V. raised its holdings in HCA Healthcare by 198.9% in the second quarter. NN Investment Partners Holdings N.V. now owns 170,204 shares of the company’s stock worth $17,463,000 after purchasing an additional 113,265 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new position in HCA Healthcare in the second quarter worth $259,000. Finally, Bank of Montreal Can raised its holdings in HCA Healthcare by 49.5% in the second quarter. Bank of Montreal Can now owns 506,077 shares of the company’s stock worth $51,922,000 after purchasing an additional 167,599 shares in the last quarter. Institutional investors own 70.84% of the company’s stock.
Shares of NYSE:HCA opened at $143.95 on Friday. HCA Healthcare Inc has a 1-year low of $74.26 and a 1-year high of $144.18. The firm has a market cap of $48.75 billion, a PE ratio of 15.92, a P/E/G ratio of 1.24 and a beta of 0.48.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 annualized dividend and a dividend yield of 0.97%. HCA Healthcare’s payout ratio is presently 21.24%.
In other news, SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction on Monday, November 5th. The stock was sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the transaction, the senior vice president now directly owns 6,184 shares in the company, valued at $835,211.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jane D. Englebright sold 6,543 shares of the stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total value of $849,673.98. Following the sale, the senior vice president now directly owns 7,443 shares in the company, valued at $966,547.98. The disclosure for this sale can be found here. Insiders have sold 22,486 shares of company stock valued at $3,079,086 over the last 90 days. Corporate insiders own 2.80% of the company’s stock.
A number of research firms have issued reports on HCA. Mizuho reiterated a “buy” rating and issued a $145.00 price objective on shares of HCA Healthcare in a report on Thursday, August 2nd. Barclays began coverage on HCA Healthcare in a report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 price objective for the company. ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. Jefferies Financial Group reiterated a “buy” rating and issued a $135.00 price objective on shares of HCA Healthcare in a report on Thursday, July 26th. Finally, Credit Suisse Group increased their price objective on HCA Healthcare from $122.00 to $143.00 and gave the stock an “outperform” rating in a report on Friday, July 27th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $141.53.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: What is a put option?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.